Table of Contents
Licensing
| Novo Nordisk Partners with The United Laboratories for US$2 B Cardiometabolic Drug Development | Abstract pdf html |
| Swati Sharan |
| GSK Signs US$2.7B+ Licensing Pact with ABL Bio for Neurodegenerative Diseases | Abstract pdf html |
| Lucy Haggerty |
This work is licensed under a Creative Commons Attribution 3.0 License.